help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leavitt, M. G.
Right arrow Articles by Pepe, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leavitt, M. G.
Right arrow Articles by Pepe, G. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*BETAMETHASONE
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 10 3831-3835
Copyright © 1999 by The Endocrine Society

Original Studies

Development of the Baboon Fetal Adrenal Gland: Regulation of the Ontogenesis of the Definitive and Transitional Zones by Adrenocorticotropin1

Maria G. Leavitt, Eugene D. Albrecht and Gerald J. Pepe

Department of Physiological Sciences, Eastern Virginia Medical School (M.G.L., G.J.P.), Norfolk, Virginia 23501; and the Departments of Obstetrics/Gynecology/Reproductive Sciences and Physiology, Center for Studies in Reproduction, University of Maryland School of Medicine (E.D.A.), Baltimore, Maryland 21201

Address all correspondence and requests for reprints to: Gerald J. Pepe, Ph.D., Department of Physiological Sciences, Eastern Virginia Medical School, P.O. Box 1980, Norfolk, Virginia 23501-1980. E-mail: gjp{at}borg.evms.edu


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Throughout gestation, the primate fetal adrenal gland is comprised of the fetal zone, which expresses the P-450 17{alpha}-hydroxylase-C17,20 lyase (P-450c17) enzyme that catalyzes the synthesis of C19 steroids used for placental estrogen production. The development of the transitional zone comprised of cortical cells that express the P-450c17 and the 3ß-hydroxysteroid dehydrogenase-isomerase (3ßHSD) enzymes for cortisol production, and the definitive zone, which expresses 3ßHSD, but not P-450c17, for mineralocorticoid synthesis, does not occur until relatively late in gestation. Although ACTH is considered essential to fetal adrenal growth and function, the role that ACTH has in the development of the transitional and definitive zones, is less clear. To answer this question, the width of these zones was determined by immunocytochemical expression of P-450c17 and/or 3ßHSD in fetal adrenal glands obtained on day 100 (mid) of gestation (term = day 184) from baboons in which ACTH was administered to the fetus on days 95–99 of gestation or on day 165 (late) of gestation from baboons in which fetal ACTH was suppressed by treatment of the mother and fetus with betamethasone on days 150–164 of gestation. At midgestation, the fetal adrenal was comprised almost exclusively of fetal zone cells and a small definitive zone (38 ± 2 µm in width), but was essentially devoid of a transitional zone (7 ± 2 µm). Treatment with ACTH enhanced (P < 0.05) the width of the transitional zone (67 ± 4 µm), but not the size of the definitive zone (10 ± 4 µm). In late gestation, the width of the definitive zone, although 2-fold greater than that on day 100, was smaller (P < 0.05) than that of the transitional zone (120 ± 15 µm), which greatly exceeded that at midgestation. Treatment with betamethasone in late gestation eliminated the transitional zone, but had no effect on the size of the definitive zone (120 ± 8 µm). These findings indicate that the development of the baboon fetal adrenal transitional zone late in gestation is dependent on fetal pituitary ACTH. In contrast, the ontogenesis of the definitive zone at midgestation and its growth in late gestation occur in the relative absence of ACTH.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
THROUGHOUT gestation, the fetal adrenal cortex of the human (1), rhesus monkey (2, 3), and baboon (4) is comprised primarily of the fetal zone, which expresses the P-450 17{alpha}-hydroxylase-C17,20-lyase (P-450c17) enzyme essential for the production of the C19 androgen dehydroepiandrosterone and its sulfate that serve as requisite precursors for placental estrogen production (5). In contrast, the transitional zone, which expresses both the 3ß-hydroxysteroid dehydrogenase-isomerase (3ßHSD) and the P-450c17 enzymes for the production of cortisol, and the definitive zone, which expresses 3ßHSD, but not P-450c17, for the production of aldosterone (1, 6), do not develop in the fetal adrenal gland until relatively late in gestation. In the baboon (7, 8) and rhesus monkey (9), ACTH of fetal pituitary origin (10) is essential to the developmental expression in late gestation of the messenger ribonucleic acids (mRNAs) and proteins for 3ßHSD and P-450c17 in and de novo cortisol production by the fetal adrenal (11, 12). It would appear, therefore, that ACTH is important to development of the transitional zone, although this remains to be confirmed by analysis of zone-specific expression of 3ßHSD and P-450c17. Moreover, it is not known whether fetal pituitary ACTH is also required for development of the definitive zone. To answer these questions, the current study compared the cellular expression of 3ßHSD and P-450c17 in fetal adrenal glands obtained at midgestation from baboons in which the fetus was administered ACTH and in late gestation from animals treated with betamethasone, which we previously demonstrated inhibited fetal pituitary POMC mRNA/ACTH (8) expression.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Animals

Fetal adrenal glands were obtained from baboons (Papio anubis) via cesarean section on day 100 (mid) or day 165 (late) of gestation (term = day 184). Baboon fetuses of midgestation were untreated (n = 5) or treated with ACTH (n = 4; Cortrosyn, Organon, Inc., West Orange, NJ) administered via maternal transabdominal im injection once daily to the fetus (25 µg/100 µL saline) on days 95–99 of gestation. In late gestation, baboons were untreated (n = 5) or treated with betamethasone (Celestone Soluspan, Schering AG, Chicago, IL) administered to the mother (6 mg) and fetus (0.6 mg) every other day between days 150–164 of gestation (n = 3).

Immunocytochemistry

Baboon fetal adrenals were fixed in 10% formalin and embedded in paraffin. Sections (4 µm) through the central portion of the gland were mounted onto SuperFrost microscope slides (Fischer Scientific, Arlington VA), deparaffinized by heating at 60 C (15 min) followed by three washes in xylene, dehydrated in graded ethanols (8), and treated with H2O2 in methanol (0.3% for 3ßHSD and 3.0% for P-450c17) to block endogenous peroxidase.

For analysis of 3ßHSD, alternate sections were preblocked for 30 min with 5% normal goat serum (Vector Laboratories, Inc., Burlingame, CA) in phosphate-buffered saline and incubated (4 C) overnight with a rabbit polyclonal antibody to antihuman 3ßHSD (supplied by Dr. Ian Mason, University of Edinburgh, Edinburgh, Scotland) diluted 1:5000 in 5% normal goat serum. After treatment with biotinylated goat antirabbit IgG (Vector Laboratories, Inc.), sections were incubated with avidin DH and horseradish peroxidase (Vectastain Elite Kit, Vector Laboratories, Inc.) and color developed with imidazole and diaminobenzidine. Sections were lightly counterstained with Gill’s hematoxylin (Fisher Scientific), and an average of six randomly selected areas (157 x 130 µm)/section (n = 4–8 sections/fetal adrenal) were examined using an Optiphot-2 microscope attached to a video-based Image 1 Analysis System (Universal Imaging Corp., West Chester, PA) to determine the width (microns) of the cell layer expressing 3ßHSD (7, 8).

For analysis of P-450c17, alternate adrenal sections were placed in Coplin jars containing 10 mmol/L sodium citrate buffer (pH 6.0; Sigma Chemical Co., St. Louis, MO) and microwaved (model JE 1540, 900W, General Electric) for 5.5 min. After cooling for 30 min, sections were washed, preblocked as for 3ßHSD, and incubated (4 C) overnight with a rabbit polyclonal antibody to antihuman P-450c17 (supplied by Dr. M. Waterman, Vanderbilt University School of Medicine, Nashville, TN) diluted 1:2000. After incubation with biotinylated goat antirabbit IgG, avidin, and biotinylated horseradish peroxidase (Vector Laboratories, Inc.), sections were incubated with H2O2, imidazole, and diaminobenzidine and examined by light microscopy as described for 3ßHSD. The mean width of cells adjacent to the capsule not expressing P-450c17 was determined by image analysis.

As described by Mesiano et al. (6), the mean width (microns) of the layer of cells expressing 3ßHSD was defined as the total width of the definitive and transitional zones. The width of this cell layer not expressing P-450c17 was defined as the definitive zone (3ßHSD positive; P-450c17 negative). This value was then subtracted from the total width of the 3ßHSD cell layer to determine the width of the transitional zone (3ßHSD and P-450c17 positive). The fetal zone was defined as those cortical cells that expressed P-450c17 but not 3ß-HSD.

Statistics

The effects of development, betamethasone, and ACTH on the width of the definitive or the transitional zones were compared by ANOVA with multiple comparison of the means by the Newman-Keuls statistic. Student’s t tests for dependent observations were used to compare the respective widths of the definitive and transitional zones in all groups.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
At midgestation, the expression of 3ßHSD was minimal and confined to a relatively narrow layer of cells adjacent to the capsule (Fig. 1AGo). Although P-450c17 was abundantly expressed in the cortex at midgestation (Fig. 1BGo), the protein was not expressed in the narrow layer of cells expressing 3ßHSD (Fig. 1Go, inset). After treatment of the fetus for 5 days with ACTH, the width of the cell layer expressing 3ßHSD was increased (Fig. 1CGo), and a significant component of these cells also expressed P-450c17 (Fig. 1DGo). These results are illustrated in Fig. 2Go, and cellular expression of P-450c17 and/or 3ßHSD are described as the mean (±SE) width of the adrenal cortex comprised of the definitive (3ßHSD-positive; P-450c17-negative) and transitional (3ßHSD- and P-450c17-positive) zones. At midgestation the fetal adrenal is comprised almost exclusively of fetal zone cells and a small definitive zone (38 ± 2 µm), but is essentially devoid of a transitional zone (7 ± 2 µm). Treatment of the fetus with ACTH at this time in gestation enhanced (P < 0.05) the width of the transitional zone (67 ± 4 µm), but not the definitive zone (10 ± 4 µm), the width of which appeared to be less than that in adrenals of untreated controls.



View larger version (91K):
[in this window]
[in a new window]
  		Figure 1. Immunocytochemical expression of 3ßHSD (A, C, E, and G) and P-450c17 (B, D, F, and H) in untreated baboons of mid- (day 100; A and B) and late (day 165; E and F) gestation and in baboons in which the fetus received ACTH on days 95–99 (C and D) or in which betamethasone (G and H) was administered to the mother (6 mg) and fetus (0.6 mg) every other day on days 150–164 of gestation (term = day 184). The cell layer expressing 3ßHSD and P-450c17 is designated the transitional zone (TZ), that expressing 3ßHSD but not P-450c17 is the definitive zone (DZ), and cells only expressing P-450c17 comprise the fetal zone (FZ). Magnification, x100; 1.7 cm = 200 µm. Inset, x200. cap, Capsularis; m, medulla.

 


View larger version (24K):
[in this window]
[in a new window]
  		Figure 2. Mean (±SE) width of the definitive and transitional zones of the fetal adrenal in untreated baboons of mid- (day 100; n = 5) and late (day 165; n = 5) gestation and baboons in which the fetus received ACTH on days 95–99 of gestation (n = 4) or in which betamethasone (n = 3) was administered to the mother (6 mg) and fetus (0.6 mg) every other day on days 150–164 of gestation (term = day 184). The widths of the definitive (3ßHSD-positive; P-450c17-negative) and transitional (3ßHSD and P-450c17-positive) zones were quantified by image analysis of zone-specific expression of 3ßHSD and/or P-450c17.

 
Compared with findings at midgestation, the expression of 3ßHSD was significantly increased in fetal adrenals of late gestation (Fig. 1EGo). Although a significant component of these 3ßHSD-positive cells adjacent to the capsule did not express P-450c17 (Fig. 1FGo), a relatively larger layer of 3ßHSD-positive cells more internal did express the P-450c17 enzyme. Thus, as summarized in Fig. 2Go, the width of the definitive zone (79 ± 5 µm), although 2-fold greater (P < 0.05) than that at midgestation, was smaller (P < 0.05) than that of the transitional zone (120 ± 15 µm), which greatly exceeded (P < 0.05) that at midgestation. Administration of betamethasone reduced the width of the layer of cells expressing 3ßHSD. However, the width of the 3ßHSD cell layer in which P-450c17 was absent was not reduced (Fig. 1Go, G and H). In contrast, there were virtually no 3ßHSD-positive cells that also expressed P-450c17. Thus, betamethasone treatment eliminated the transitional zone, but not the definitive zone (120 ± 8 µm), the width of which appeared to be greater than that in adrenals of untreated baboons during late gestation. The size of the fetal zone also appeared to be reduced by treatment with betamethasone (Fig. 1HGo).


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
The results of the present study indicate that the width of the zone of the baboon fetal adrenal cortex expressing both 3ßHSD and P-450c17 was negligible at midgestation when fetal ACTH levels are low (7, 10), enhanced by treatment of the fetus at midgestation with ACTH, and increased in late gestation when fetal ACTH levels are elevated (8, 10). Moreover, in baboons in which fetal pituitary POMC mRNA/ACTH expression was suppressed in late gestation by treatment with betamethasone (8), the development of cortical cells expressing both 3ßHSD and P-450c17 was prevented. These developmental and betamethasone-induced changes in 3ßHSD and P-450c17 were accompanied by similar alterations in fetal cortisol production, which we previously demonstrated was negligible at midgestation, increased significantly at term (12, 13), and was virtually eliminated in betamethasone-treated baboons in late gestation (8). Collectively, these in vivo experimental observations indicate that the development of the transitional zone and the ontogenesis of fetal adrenal cortisol production in the baboon fetal adrenal gland in late gestation are dependent on fetal pituitary ACTH. A similar role for ACTH has been proposed by Coulter et al. (9), who demonstrated that the number of fetal adrenal cells expressing 3ßHSD and presumed to be cells of the transitional zone based on location and histologic appearance was increased after treatment of the late gestation rhesus monkey fetus with metyrapone.

The results of present study also indicate that the size of the definitive zone, like that of the transitional zone, was increased between mid- and late gestation. However, in contrast to the transitional zone, treatment with ACTH at mid-gestation or suppression of endogenous ACTH by betamethasone in late gestation did not alter the width of the definitive zone. Hypophysectomy of the sheep fetus at mid- to late gestation also had no effect on the apparent width of the fetal adrenal glomerulosa (i.e. definitive zone), as based on histology, although the size of the developing fasiculata (i.e. transitional zone) was dramatically reduced (14). Histological (15, 16) and stereological (17) analyses of the human fetal adrenal have also shown that growth of the zona glomerulosa was not affected by fetal anencephaly, i.e. in the absence of ACTH. It appears, therefore, that the development of the definitive zone of the fetal adrenal is regulated by factors other than ACTH. Earlier studies in the adult rat also demonstrated that the width of the zona glomerulosa of the adrenal was not significantly affected by hypophysectomy, i.e. removal of pituitary ACTH (18). In the adult adrenal, glomerulosa cell function is regulated by angiotensin II via interaction with the AT1 receptor. Interestingly, human fetal adrenal cortical cells primarily express the AT2 receptor (19). The AT1 receptors apparently are only expressed in a few layers of cortical cells at the periphery (presumed definitive zone) of the fetal adrenal gland (19). Studies of the regulation and role of AT1 and AT2 receptors in the primate fetal adrenal gland, however, remain to be performed. Activin and inhibin have also been postulated to modulate fetal adrenal development (1). Recently, we demonstrated that the baboon fetal adrenal expresses abundant quantities of inhibin {alpha}-subunit in fetal zone cells throughout the course of gestation (20). However, inhibin {alpha}-subunit was not detected in the outer layer of definitive zone cells expressing 3ßHSD in late gestation. Although the role of inhibin on adrenal cellular maturation remains to be determined, in vitro studies suggest that the presence of {alpha}-subunit may serve to limit the production of activins (dimers of ß-subunits), which have been shown to inhibit fetal adrenal cell proliferation as well as stimulate ACTH-dependent cortisol production (21). Finally, we previously demonstrated that estrogen of placental origin acts on the baboon fetal adrenal gland in vitro (22) and in vivo (23) to suppress ACTH-dependent dehydroepiandrosterone production by fetal zone cells, apparently by interaction with the estrogen receptor, which is expressed in the cells of the fetal zone (24). Interestingly, estrogen receptor was also expressed in relatively high levels in definitive zone cells, and therefore, estrogen may also act to coordinate the development and/or function of the baboon fetal adrenal definitive zone.

In summary, the current study demonstrated that the development of the baboon fetal adrenal transitional zone late in gestation is dependent on fetal pituitary ACTH. In contrast, the ontogenesis of the definitive zone at midgestation and its growth and development in late gestation occurred in the relative absence of ACTH, suggesting that factors other than ACTH regulate maturation of the primate fetal adrenal definitive zone.


   Acknowledgments
 
The authors sincerely appreciate the secretarial assistance of Ms. Sandra Huband, Mr. Nicholas Zachos for help with the preparation of the photomicrographs, and Ms. Pamela Brien and Reinhart B. Billiar, Ph.D., for assistance with the immunocytochemistry. The authors thank Dr. Michael Waterman of Vanderbilt University School of Medicine (Nashville, TN) and Dr. Ian Mason of the University of Edinburgh (Edinburgh, Scotland) for the antibodies to P-450c17 and 3ß-HSD, respectively.


   Footnotes
 
1 This work was supported by NIH Research Grant R01-HD-13294. Back

Received April 21, 1999.

Revised June 28, 1999.

Accepted July 1, 1999.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Mesiano S, Jaffe RB. 1997 Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev. 18:378–403.[Abstract/Free Full Text]
  2. Lanman JT. 1957 The adrenal fetal zone: its occurrence in primates and a possible relationship to chorionic gonadotropin. Endocrinology. 61:684–691.
  3. McNulty WP, Novy MJ, Walsh SW. 1981 Fetal and postnatal development of the adrenal gland in Macaca mulatta. Biol Reprod. 25:1079–1089.[Abstract]
  4. Pepe GJ, Albrecht ED. 1990 Regulation of the primate fetal adrenal cortex. Endocr Rev. 11:151–176.[Abstract/Free Full Text]
  5. Albrecht ED, Pepe GJ. 1990 Placental steroid hormone biosynthesis in primate pregnancy. Endocr Rev. 11:124–150.[Abstract/Free Full Text]
  6. Mesiano S, Coulter CL, Jaffe RB. 1993 Localization of cytochrome P450 cholesterol side-chain cleavage, cytochrome P450 17{alpha}-hydroxylase/17,20-lyase, and 3ß-hydroxysteroid dehydrogenase isomerase steroidogenic enzymes in human and rhesus monkey fetal adrenal glands: reappraisal of functional zonation. J Clin Endocrinol Metab. 77:1184–1189.[Abstract]
  7. Aberdeen GW, Leavitt MG, Pepe GJ, Albrecht ED. 1998 Effect of maternal betamethasone administration at midgestation on baboon fetal adrenal gland development and adrenocorticotropin receptor messenger ribonucleic acid expression. J Clin Endocrinol Metab. 83:976–982.[Abstract/Free Full Text]
  8. Leavitt MG, Aberdeen GW, Burch MG, Albrecht ED, Pepe GJ. 1995 Inhibition of fetal adrenal adrenocorticotropin receptor messenger ribonucleic acid expression by betamethasone administration to the baboon fetus in late gestation. Endocrinology. 138:2705–2712.[Abstract/Free Full Text]
  9. Coulter CL, Goldsmith PC, Mesiano S, Voytek CC, Martin MC, Mason JI, Jaffe RB. 1996 Functional maturation of the primate fetal adrenal in vivo. II. Ontogeny of corticosteroid synthesis is dependent upon specific zonal expression of 3ß-hydroxysteroid dehydrogenase/isomerase. Endocrinology. 137:4953–4959.[Abstract]
  10. Pepe GJ, Davies WA, Albrecht ED. 1994 Activation of the baboon fetal pituitary-adrenocortical axis at midgestation by estrogen: enhancement of fetal pituitary proopiomelanocortin messenger ribonucleic acid expression. Endocrinology. 135:2581–2587.[Abstract]
  11. Pepe GJ, Albrecht ED. 1991 Activation of the baboon fetal pituitary-adrenocortical axis at midgestation by estrogen: adrenal {Delta}5-3ß-hydroxysteroid dehydrogenase and 17{alpha}-hydroxylase-17,20-lyase activity. Endocrinology. 128:2395–2401.[Abstract/Free Full Text]
  12. Pepe GJ, Albrecht ED. 1984 Transuteroplacental metabolism of cortisol and cortisone during mid- and late gestation in the baboon. Endocrinology. 115:1946–1951.[Abstract/Free Full Text]
  13. Berghorn KA, Albrecht ED, Pepe GJ. 1995 Activation of the baboon fetal pituitary-adrenocortical axis at midgestation by estrogen: responsivity of the fetal adrenal gland to adrenocorticotropic hormone in vitro. Biol Reprod. 53:996–1002.[Abstract]
  14. Robinson PM, Comline RS, Fowden AL, Silver M. 1983 Adrenal cortex of fetal lamb: changes after hypophysectomy and effects of synacthen on cytoarchitecture and secretory activity. Q J Exp Physiol. 68:15–27.[Abstract/Free Full Text]
  15. Benirschke K. 1956 Adrenals in anencephaly and hydrocephaly. Obstet Gynecol. 8:412–425.[Medline]
  16. Gray ES Abramovich DR. 1980 Morphologic features of the anencephalic adrenal gland in early pregnancy. Am J Obstet Gynecol. 137:491–495.[Medline]
  17. Bocian-Sobkowska J, Malendowicz LK, Wozniak W. 1997 Comparative stereological study on zonation and cellular composition of adrenal glands of normal and anencephalic human fetuses. I. Zonation of the gland. Histol Histopathol. 12:311–317.[Medline]
  18. Nickerson PA, Brownie AC. 1975 Effect of hypophysectomy on the volume and ultrastructure of zona glomerulosa in rat adrenal. Endocrinol Exp. 9:187–196.[Medline]
  19. Breault L, LeHoux J-G, Gallo-Payet N. 1996 The angiotensin AT2 receptor is present in the human fetal adrenal gland throughout the second trimester of gestation. J Clin Endocrinol Metab. 81:3914–3922.[Abstract/Free Full Text]
  20. Billiar RB, Leavitt MG, Smith P, Albrecht ED, Pepe GJ. Functional capacity of fetal zone cells of the baboon fetal adrenal gland: a major source of {alpha}-inhibin. Biol Reprod. 61:142–146.
  21. Spencer SJ, Rabinovici J, Mesiano S, Goldsmith PC, Jaffe RB. 1992 Activin and inhibin in the human adrenal gland: regulation and differential effects in fetal and adult cells. J Clin Invest. 90:142–149.
  22. Albrecht ED, Pepe GJ. 1987 Effect of estrogen on dehydroepiandrosterone formation by baboon fetal adrenal cells in vitro. Am J Ob Gynecol. 156:1275–1278.[Medline]
  23. Pepe GJ, Waddell BJ, Albrecht ED. 1989 Effect of estrogen on pituitary peptide-induced dehydroepiandrosterone secretion in the baboon fetus at midgestation. Endocrinology. 125:1519–1524.[Abstract/Free Full Text]
  24. Albrecht ED, Babischkin JS, Davies WA, Leavitt MG, Pepe GJ. Identification and developmental expression of the estrogen receptor {alpha} and ß in the baboon fetal adrenal gland. Endocrinology. In press.



This article has been cited by other articles:


Home page
 J EndocrinolHome page
A. Dumitrescu, G. W Aberdeen, G. J Pepe, and E. D Albrecht
Developmental expression of cell cycle regulators in the baboon fetal adrenal gland
J. Endocrinol., January 1, 2007; 192(1): 237 - 247.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Ishimoto, D. G. Ginzinger, T. Matsumoto, Y. Hattori, M. Furuya, K. Minegishi, M. Tanaka, Y. Yoshimura, and R. B. Jaffe
Differential Zonal Expression and Adrenocorticotropin Regulation of Secreted Protein Acidic and Rich in Cysteine (SPARC), a Matricellular Protein, in the Midgestation Human Fetal Adrenal Gland: Implications for Adrenal Development
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3208 - 3214.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Ishimoto, D. G. Ginzinger, and R. B. Jaffe
Adrenocorticotropin Preferentially Up-Regulates Angiopoietin 2 in the Human Fetal Adrenal Gland: Implications for Coordinated Adrenal Organ Growth and Angiogenesis
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1909 - 1915.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Simard, M.-L. Ricketts, S. Gingras, P. Soucy, F. A. Feltus, and M. H. Melner
Molecular Biology of the 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4 Isomerase Gene Family
Endocr. Rev., June 1, 2005; 26(4): 525 - 582.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
D. M. Duffy, C. L. Seachord, and B. L. Dozier
Microsomal prostaglandin E synthase-1 (mPGES-1) is the primary form of PGES expressed by the primate periovulatory follicle
Hum. Reprod., June 1, 2005; 20(6): 1485 - 1492.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
E. D. Albrecht, R. B. Billiar, G. W. Aberdeen, J. S. Babischkin, and G. J. Pepe
Expression of Estrogen Receptors {alpha} and {beta} in the Fetal Baboon Testisand Epididymis
Biol Reprod, April 1, 2004; 70(4): 1106 - 1113.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. A. Feltus, W. J. Kovacs, W. Nicholson, C. M. Silva, S. K. Nagdas, N. A. Ducharme, and M. H. Melner
Epidermal Growth Factor Increases Cortisol Production and Type II 3{beta}-Hydroxysteroid Dehydrogenase/{Delta}5-{Delta}4-Isomerase Expression in Human Adrenocortical Carcinoma Cells: Evidence for a Stat5-Dependent Mechanism
Endocrinology, May 1, 2003; 144(5): 1847 - 1853.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Mapes, A. F. Tarantal, C. R. Parker, F. M. Moran, J. M. Bahr, L. Pyter, and A. J. Conley
Adrenocortical Cytochrome b5 Expression during Fetal Development of the Rhesus Macaque
Endocrinology, April 1, 2002; 143(4): 1451 - 1458.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Breault, E. Chamoux, J.-G. LeHoux, and N. Gallo-Payet
Localization of G Protein {{alpha}}-Subunits in the Human Fetal Adrenal Gland
Endocrinology, December 1, 2000; 141(12): 4334 - 4341.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leavitt, M. G.
Right arrow Articles by Pepe, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leavitt, M. G.
Right arrow Articles by Pepe, G. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*BETAMETHASONE

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals